Healthy ExtractsHYEX 54 Days Payable is 18.85 as of Mar. 2026, which is 36% below its 10-year median of 29.49. GuruFocus rates HYEX with a GF Score™ of 54/100 and a GF Value™ of $1.64 (Fairly Valued). The stock has 2 warning signs investors should review. Among 922 Drug Manufacturers companies, Healthy Extracts ranks worse than 95.99% on this metric.
The historical rank and industry rank for Healthy Extracts's Days Payable or its related term are showing as below:
HYEX'
s Days Payable Range Over the Past 10 Years
Min: 8.46 Med: 29.49 Max: 3467.5
Current: 18.99
During the past 12 years, Healthy Extracts's highest Days Payable was 3467.50. The lowest was 8.46. And the median was 29.49.
HYEX's Days Payable is ranked worse than 95.99% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.61
vs HYEX: 18.99
Healthy Extracts's Days Payable
increased
from Mar. 2025 (11.99) to Mar. 2026 (18.85).
It may suggest that Healthy Extractsdelayed paying its suppliers.
Healthy Extracts Days Payable Related Terms
Healthy Extracts Days Payable Historical Data
* Premium members only.
The historical data trend for Healthy Extracts's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthy Extracts Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's Days Payable distribution charts can be found below:
* The bar in red indicates where Healthy Extracts's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Healthy Extracts's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthy Extracts (HYEX) has a Days Payable of 18.85 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Healthy Extracts and its competitors. This is 36% below median its historical median of 29.49. Over the past decade, Healthy Extracts' Days Payable has ranged from 8.46 to 3,467.50. According to the industry distribution chart, Healthy Extracts ranks #885 out of 922 companies in the Drug Manufacturers industry, placing it in the top 96%.
Is Healthy Extracts' Days Payable too high?
Healthy Extracts' current Days Payable of 18.85 is 36% below median its 10-year median of 29.49. Over the past 10 years, this metric has ranged from a low of 8.46 to a high of 3,467.50. The Drug Manufacturers industry median Days Payable is 90.61. Healthy Extracts' value of 18.85 is 79.2% below this industry median. Based on the distribution chart, Healthy Extracts ranks #885 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Healthy Extracts has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Healthy Extracts' Days Payable compare to ZYBT and MRMD?
According to the Drug Manufacturers industry distribution chart, Healthy Extracts ranks #885 out of 922 companies for Days Payable. This places Healthy Extracts in the lower half of its industry. The industry median Days Payable is 90.61. Healthy Extracts' value of 18.85 is 79.2% below this benchmark. Historically, Healthy Extracts' own Days Payable has ranged from 8.46 to 3,467.50 over the past decade. While the company's 10-year median is 29.49 vs. the industry median of 90.61, Healthy Extracts has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthy Extracts's current Days Payable of 18.85 is 79.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Healthy Extracts and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthy Extracts's current Days Payable is 18.85, which is 36% below median its own 10-year median of 29.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthy Extracts stock overvalued right now?
Based on GuruFocus' analysis, Healthy Extracts (HYEX) is currently considered Fairly Valued. The stock's GF Value™ is $1.64, compared to a current price of $1.61 — trading 1.8% below its estimated fair value. The current Days Payable is 18.85, which is 36% below median its 10-year median of 29.49 and 79.2% below the Drug Manufacturers industry median of 90.61. Healthy Extracts' overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Healthy Extracts (HYEX), the current Days Payable is 18.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthy Extracts (HYEX) Overvalued in 2026?
Based on GuruFocus' analysis, Healthy Extracts stock appears to be undervalued.
The current stock price of $1.61 is trading 1.8% below its estimated GF Value™ of $1.64.
GuruFocus considers Healthy Extracts to be Fairly Valued.
Key valuation signals for HYEX:
Days Payable: 18.85 (36% below median its 10-year median of 29.49)
GF Value™: $1.64 vs. price of $1.61 (1.8% below fair value)
Industry Position: 79.2% below the Drug Manufacturers median (#885 of 922)
No single metric tells the full story. See the HYEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol, metabolic and cardiovascular health. Its products are distributed in the United States and Mexico. Its operating segment includes, Health Supplements and Corporate. The company generates maximum revenue from the Health Supplements segment.
54GF Score
Get the complete analysis for HYEX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HYEX has been successfully added to your 
